Modulation of Extracellular Matrix Composition and Chronic Inflammation with Pirfenidone Promotes Scar Reduction in...

Area of Science:

• Ophthalmology
• Regenerative Medicine
• Molecular Biology

Background:

• Retinal wound repair is complex and crucial for preventing photoreceptor loss.
• Understanding the molecular mechanisms of retinal healing is vital for developing new treatments.
• Laser-induced retinal degeneration models offer insights into wound healing processes.

Purpose of the Study:

• To investigate the molecular and cellular sequence of wound healing in a laser-induced retinal degeneration model.
• To evaluate the efficacy of pirfenidone in modulating scar formation and inflammation.
• To assess the impact of treatment on photoreceptor layer regeneration.

Main Methods:

• Utilized a murine laser-induced retinal degeneration model (532-nm laser).
• Monitored wound healing up to 49 days post-laser, analyzing extracellular matrix proteins and myofibroblast activity.
• Quantified gene expression of extracellular matrix and adhesion molecules via RNA measurements.
• Administered pirfenidone (10 mg/kg) in drinking water to assess its anti-fibrotic and anti-inflammatory effects.

Main Results:

• Observed upregulated collagen expression during late regenerative phases.
• Detected sustained inflammation in the damaged retinal tissue.
• Pirfenidone treatment mitigated scar tissue formation by downregulating collagen and reducing inflammatory markers.
• Photoreceptor layer regeneration was not observed with pirfenidone treatment.

Conclusions:

• Laser-induced retinal injury leads to sustained inflammation and collagen upregulation.
• Pirfenidone effectively reduces scar formation and inflammation in this model.
• Current pirfenidone treatment does not promote photoreceptor regeneration, highlighting the complexity of retinal repair.